IL17A and inflammatory bowel disease: Both in in vitro and in vivo models, UA improved the circadian rhythm dysregulation of clock genes and tight junction genes induced by TNF-α + IL-17A treatment and IBD inflammation (Figure 2, Figure 3 and Figure 5).